13 unknown. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Unknown 13 |
Follow Patient Compliance: new trials by email Literature Review of Patient Compliance trials Research Report on Patient Compliance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Motor Function Efficacy of Pharmacological Treatments Targeting Energy Metabolism, in Parkinson's Patients Terazosin - Parkinson Disease, Gait Analysis | Phase 4 | Unknown | I.R.C.C.S. Fondazione Santa Lucia | 50 | 2023-12-01 | 2023-09-22 |
| Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker Piracetam - Drug Adherence Marker | Phase 4 | Unknown | The Netherlands Cancer Institute | 10 | 2023-07-03 | 2023-06-26 |
| Use of Mysimba in Patients With Weight Regain After Bariatric Surgery Naltrexone-Bupropion Combination - Obesity, Morbid, Bariatric Surgery Candidate | Phase 4 | Unknown | Zuyderland Medisch Centrum | 116 | 2023-03-21 | 2023-05-30 |
| Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds Nocardia rubra Cell Wall Skeleton, Silver ions dressing - Diabetic Foot Ulcer, Therapy, Directly Observed | Phase 4 | Unknown | The Affiliated Hospital of Xuzhou Medical University | 116 | 2022-05-20 | 2022-05-10 |
| Long-term Effect of an Health Education Program on Daily Physical Activity in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease Health education program, Conventional management - Chronic Obstructive Pulmonary Disease | Phase 4 | Unknown | Hospital Universitario La Paz | 128 | 2016-10-01 | 2023-03-03 |
| Digital Health Feedback System for Longitudinal Measurement of Medication Adherence During Anti-Retroviral (ARV)Therapy Digital Health Feedback System - HIV | Phase 4 | Unknown | University of California, San Diego | 100 | 2016-06-01 | 2022-12-23 |
| Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia Aripiprazole Once-Monthly, Oral Antipsychotic (i.e. aripiprazole, risperidone, lurasidone, quetiapine, olanzapine, ziprasidone, etc) - Schizophrenia | Phase 4 | Unknown | Matt Byerly | 200 | 2014-12-01 | 2015-06-08 |
| Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant Advagraf, Prograf - Adherence to Medication Regime | Phase 4 | Unknown | National Taiwan University Hospital | 90 | 2014-05-09 | 2019-04-02 |
| Multidisciplinary and Coordinated Follow-up Based on a Telemonitoring Web Platform for Improving CPAP Compliance in Low Cardiovascular Risk Sleep Apnea Patients : OPTISAS 1 Study Continuous Positive Airway Pressure (CPAP) in sleep apnea patients - Sleep Apnea Syndrome, Low Cardiovascular Risk | Phase 4 | Unknown | Fédération Française de Pneumologie | 936 | 2013-02-01 | 2014-09-05 |
| Reduction of Cardiovascular Risk in Severe Mental Illness Lifestyle counseling - Severe Mental Illness, Schizophrenia | Phase 4 | Unknown | Consorci Hospitalari de Vic | 391 | 2010-08-01 | 2010-08-16 |
| The Effect of Education on Patient Compliance American Academy of Ophthalmology Glaucoma Educational Tape - Glaucoma | Phase 4 | Unknown | Michael E. DeBakey VA Medical Center | 40 | 2005-03-01 | 2006-09-15 |
| PREvent First Episode Relapse (PREFER) atypical antipsychotics:oral vs. long-acting route, Family Psychoeducation - Schizophrenia | Phase 4 | Unknown | State University of New York - Downstate Medical Center | 80 | 2004-11-01 | 2008-03-31 |
| Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment phone call, amlodipine (calcium chanel blocker) and losartan (at1 antagonist), atenolol (beta blocker) and hydrochlorothiazide (diuretic) - Blood Pressure | Phase 4 | Unknown | University of Sao Paulo | 400 | 1999-03-01 | 2008-12-23 |
Medication Adherence (6) · Schizophrenia (3) · Directly Observed Therapy (2) · Bipolar Disorder (1) · Diabetic Foot (1) · Glaucoma (1) · Health Education (1) · Hypertension (1) · Mental Disorders (1) · Metabolic Diseases (1) · Mood Disorders (1) · Obesity, Morbid (1) · Parkinson Disease (1) · Personality Disorders (1)
Behavior (13) · Health Behavior (13) · Patient Acceptance of Health Care (13) · Treatment Adherence and Compliance (13) · Medication Adherence (3) · Pathological Conditions, Signs and Symptoms (3) · Schizophrenia Spectrum and Other Psychotic Disorders (3) · Cardiovascular Diseases (2) · Disease Attributes (2) · Mental Disorders (2) · Nervous System Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathologic Processes (2) · Respiratory Tract Diseases (2)
Adrenergic beta-Antagonists (1) · Amlodipine (1) · Antipsychotic Agents (1) · Atenolol (1) · Continuous Positive Airway Pressure (1) · Control Groups (1) · Diuretics (1) · Hydrochlorothiazide (1) · Lisosan G (1) · Losartan (1) · Lurasidone Hydrochloride (1) · Naltrexone-Bupropion combination (1) · Olanzapine (1) · Piracetam (1) · Quetiapine Fumarate (1)
Consorci Hospitalari de Vic (1) · Fédération Française de Pneumologie (1) · Hospital Universitario La Paz (1) · I.R.C.C.S. Fondazione Santa Lucia (1) · Matt Byerly (1) · Michael E. DeBakey VA Medical Center (1) · National Taiwan University Hospital (1) · State University of New York - Downstate Medical Center (1) · The Affiliated Hospital of Xuzhou Medical University (1) · The Netherlands Cancer Institute (1) · University of California, San Diego (1) · University of Sao Paulo (1) · Zuyderland Medisch Centrum (1)
United States (4) · Spain (2) · Brazil (1) · France (1) · Netherlands (1) · Taiwan (1)
Alwin Huitema, Prof. Dr. (1) · Antonella Peppe, MD, PhD (1) · Chin-Yuan Lee (1) · Constance A Benson, MD (1) · Decio Mion Jr, MD (1) · Francisco Garcia-Rio, MD (1) · Jan Willem Greve, MD, PhD, professor (1) · Matt Byerly, MD (1) · Peter J Weiden, M.D. (1) · Sara H Browne, MD, MPH (1) · Silvia Orengo-Nania, m.d. (1)
PMID 19906343, PMID 22938760, PMID 36094829
R01MH110057 (1)